1 / 19

Buprenorphine: A Promising Pharmacotherapy for the Treatment of Opioid Dependence

Buprenorphine: A Promising Pharmacotherapy for the Treatment of Opioid Dependence . Laura Haynes and Larissa Williams. Overview . Heroin Leading treatment in the U.S.: Methadone Experimental treatment: Buprenorphine Naltrexone Combination Treatment: Buprenorphine and Naltrexone

barney
Download Presentation

Buprenorphine: A Promising Pharmacotherapy for the Treatment of Opioid Dependence

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Buprenorphine: A Promising Pharmacotherapy for the Treatment of Opioid Dependence Laura Haynes and Larissa Williams

  2. Overview • Heroin • Leading treatment in the U.S.: Methadone • Experimental treatment: Buprenorphine • Naltrexone • Combination Treatment: Buprenorphine and Naltrexone • Differing Approaches and Pharmaco-Philosophy

  3. History of Heroin Use in the U.S. • Civil War • New wonder drug: Heroin • Drug Kits • Unregulated and sold legally in the U.S. until 1920 when Congress enacted the Dangerous Drug Act. http://www.heroinaddiction.com/heroin_hist.html

  4. Heroin: Why is it so addictive? Heroin is converted to morphine. Physical dependence/addiction. Psychological dependence

  5. http://165.112.78.61/pubs/Teaching/Teaching2/largegifs/slide17.gifhttp://165.112.78.61/pubs/Teaching/Teaching2/largegifs/slide17.gif

  6. Structure of Heroin and Agonists Used to Treat Its Addiction Heroin Methadone Buprenorphine

  7. Common Treatment for Addiction • Methadone is used as a replacement for heroin, in treatments aimed at either abstinence or maintenance. 

  8. New Treatment • Buprenorphine hydrochloride is a derivative of the morphine alkaloid thebaine. • Buprenorphine is a partial agonist at the µ-opioid receptor and an antagonist at the κ-receptor www.chemfinder.com

  9. Side Effects (actual functions?) • Drowsiness • Vomiting • Nausea • Constipation • Itching and Perspiration • Mood Changes

  10. Comparison of Methadone with Buprenorphine • Agonist type • full agonist at m-opioid receptor • Partial agonist at m-opioid receptor and weak agonist at k-receptor • Medication form • tablets, solution (oral and parenteral) • parenteral form and sublingual tablet • Dose • 20 to 100 mg, orally • 8 to 24 mg, sublingually • Frequency of administration • daily • daily to three times per week • Potential for abuse • studies in monkeys show to be not as effective at suppressing self administration • efficacy of dose reaches a plateau • high dose increases risk of precipitated withdrawal • Withdrawal • slow dissociation kinetics from receptor result in less severe withdrawal than methadone

  11. Naltrexone • Opioid antagonist • blocks opioid induced effects, such as euphoria • lessens reinforcing effects • Limited usefulness • low patient compliance because requires abstinence www.chemfinder.com

  12. STOP USE Buprenorphine Naltrexone Combination Treatment: Buprenorphine and Naltrexone • Direct transfer from buprenorphine to naltrexone without detoxification • Combination product

  13. Social Implications • Scientific evidence of usefulness is NO indication of acceptance • Available in Europe since 1996 • Approved relatively recently in the United States • Why?

  14. Differing Approaches www.flags.net

  15. Three Different Approaches(France, Australia, United States) • Acceptance of scientific research • easily accepted and liberal implementation of use in 1996 • large clinical studies and synthesis of worldwide data; approved in 2001 • slow to conduct large-scale clinical trials; long approval process • Distribution and Use • widely available, 10 times more people treated than with methadone • guidelines for use set forth by the government • methadone treatment facilities outside of mainstream medical community • Results • some illegal use resulting in overdose and death • decrease in the number of heroin related deaths

  16. Philosophy of Addiction Treatments in the United States • Current Situation… • ideology of abstinence • suspicious of medicinal treatments • What could be done… • inform and involve medical community • lessen paperwork and red tape • Resulting in… • shift from treatment system based in ideology to science • pharmacological treatment within a social and political context

  17. Conclusion • Heroin and methadone are highly addictive • Buprenorphine and naltrexone are less addictive • New way of approaching opioid addiction/disease

  18. References Journals • Bickel, W.K. and Ammasm L. 1995. Buprenorphine treatment of opioid dependence: A review. Experimental and Clinical Psychopharmacology, 3: 477-489. • Cherubin, C.E.; Sapira, J.D. 1993. The medical complications of drug addiction and the medical assessment of the intravenous drug user: 25 years later. Annals of Internal Medicine, 119: 1017-1028. • Chiang, C.N., and Hawks, R.L. 2003. Pharmacokinetics of the combination tablet of buprenorphine and naloxone. Drug and Alcohol Dependence, 70: S39-S47. • Johnson, R.E., Strain, E.C., and Ammas, L. 2003. Buprenorphine: how to use it right. Drug and Alcohol Dependence, 70: S59-S77. • Ling, W., and Wesson, D.R. 2003. Clinical efficacy of buprenorphine: comparisons to methadone and placebo. Drug and Alcohol Dependence,70: S49-S57. • Ling, W. and Smith, D. 2002. Buprenorphine: blending practice and research. Journal of Substance Abuse Treatment, 23: 87-92. • Mather, L.E. 1987. Opioid pharmacokinetics in relation to their effects. Anaesth Intensive Care,1:15-22. • O’Conner, P.G.; Fiellin, D.A. 2000. Pharmacologic Treatment of Heroin-Dependent Patients. Annals of Internal Medicine, 133: 40-54. • Zhi-Min, L., Xian-Xiang, L., Yue, M., Ping, O., and Xin, A. 2003. Evaluation on drug dependence of buprenorphine. Acta Pharmacol Sin, 24: 428-452. Websites • http://users.rcn.com/jkimball.ma.ultranet/BiologyPages/C/CNS.html • http://www.doctorsreviewservice.com/opiates.htm • http://www.adf.org.au/drughit/smackcat13.html • http://www.chemfinder.com Books • Blain, Jack, D., ed. Bruprenorphine: An Alternative Treatment for Opioid Dependence. Rockville, MD: US Department of Health and Human Services, 1992.

  19. Got Questions?

More Related